InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.65
(
0.07%
)
Bitcoin
62,728.72
(
3.21%
)
Post# of 3647
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

johnnymcgriffin347

Send PM Follow Ignore
Followers 0
Posts 541
Boards Moderated 0
Alias Born 11/13/2018

johnnymcgriffin347

Re: None

Wednesday, 04/28/2021 11:37:44 PM

Wednesday, April 28, 2021 11:37:44 PM

Post# of 3647
Zhittya Genesis Medicine Announces Phase I Clinical Trials

Zhittya Genesis Medicine has announced that it has been approved to conduct a Phase I Clinical Trial using FGF-1 to treat ALS. This is in addition to the various clinical activity that Zhittya Genesis Medicine has conducted over the past six years.

How much has CVBT's/VT's clinical trials moved in the last 6 years? There seems to be absolutely no activity in the clinical development department, a principle aspect of any biotechnology company.

DOES CVBT/VT EVEN HAVE FGF-1????????????
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up